UP!

MCS $21.47

MCS target price
21.47
0
0

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q3 2022 2022-11-01 Future report Set alerts
Q2 2022 2022-08-03 0.24 0.24
Q1 2022 2022-05-05 -0.48 -0.48
Q4 2021 2022-03-03 0.18 0.18
Q3 2021 2021-11-03 0.06 0.06
Q2 2021 2021-08-04 -0.76 -0.76
Q1 2021 2021-05-05 -0.93 -0.93
Q4 2020 2021-03-04 -1.49 -1.49
Q3 2020 2020-11-03 -1.30 -1.30
Q2 2020 2020-08-04 -0.89 -0.89

Ratings

2016-05-04 Reiterated Rating B. Riley Buy $25.50
2016-04-29 Reiterated Rating B. Riley Buy $25.50
2016-03-30 Lower Price Target B. Riley $27.75 to $25.50
2016-03-01 Reiterated Rating B. Riley Buy $26.00
2016-02-25 Reiterated Rating B. Riley Buy $26.00
2015-12-20 Reiterated Rating B. Riley Buy $26.00
2015-12-18 Reiterated Rating Gabelli Buy $31.00
2015-12-15 Lower Price Target B. Riley Buy $26.00
2015-10-15 Initiated Coverage Gabelli Buy $30.00 to $30.00
2015-09-22 Reiterated Rating B. Riley Buy $27.00
2015-09-17 Boost Price Target B. Riley Buy $26.00 to $27.00
2015-08-29 Reiterated Rating B. Riley Buy $26.00
2015-08-23 Boost Price Target B. Riley Buy $23.00 to $26.00
2015-07-29 Upgrade B. Riley Buy $23.00
2015-07-25 Reiterated Rating B. Riley Neutral $22.75
2015-07-24 Upgrade B. Riley Neutral to Buy $22.75 to $23.00
2015-07-20 Reiterated Rating B. Riley Neutral $22.75
2015-04-13 Downgrade B. Riley Buy to Neutral $25.00 to $22.75
2015-03-25 Reiterated Rating B. Riley Buy $25.00
2015-03-18 Reiterated Rating B. Riley Buy $23.00
2015-03-11 Reiterated Rating B. Riley Buy $23.00
2014-12-24 Reiterated Rating B. Riley Buy $21.50
2014-12-17 Reiterated Rating B. Riley Buy $21.00
2014-12-10 Reiterated Rating B. Riley Buy $21.00
2014-09-17 Lower Price Target Benchmark Co. $24.07
2014-09-10 Upgrade B. Riley Neutral to Buy $21.00
2014-07-09 Initiated Coverage Benchmark Co. Buy $24.11
2014-06-24 Initiated Coverage Barrington Research Outperform $24.00
2014-04-03 Downgrade B. Riley Buy to Neutral $18.00
2014-03-21 Boost Price Target B. Riley $17.00 to $18.00
2010-07-13 Upgrade Robert W. Baird Neutral to Outperform $13
2010-03-23 Downgrade Robert W. Baird Outperform to Neutral $13
2008-08-15 Downgrade Robert W. Baird Outperform to Neutral $19 to $20
2016-05-04 Reiterated Rating B. Riley Buy $25.50
2016-04-29 Reiterated Rating B. Riley Buy $25.50
2016-03-30 Lower Price Target B. Riley $27.75 to $25.50
2016-03-01 Reiterated Rating B. Riley Buy $26.00
2016-02-25 Reiterated Rating B. Riley Buy $26.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
Marcus Gregory S President and CEO 1.46%  (127741) MCS /
KISSINGER THOMAS F VP, General Counsel and Secy 0.82%  (71521) MCS /
NEIS DOUGLAS A CFO and Treasurer 0.81%  (70783) MCS /
RODRIGUEZ ROLANDO B Pres. & CEO - Marcus Theatres 0.63%  (55100) MCS /
MILSTEIN PHILIP L 0.40%  (35244) MCS /
SELIG ALLAN H 0.35%  (30673) MCS / ODC /
ERICSON JAMES D 0.26%  (22935) MCS /
HAASE BRONSON J 0.25%  (21877) MCS /
HOEKSEMA TIMOTHY E 0.19%  (16914) MCS /
MCKEITHAN DANIEL F JR 0.17%  (14655) MCS /
STARK BRIAN JAY 0.16%  (13564) MCS /
Rose Kirk Alan Pres.- Marcus Hotels & Resorts 0.11%  (9300) CRMB / MCS /
OLSON BRUCE J Senior Vice President 0.07%  (6229) MCS /
BAUM DAVID M 0.06%  (5474) MCS /
Gehl Katherine M. 0.06%  (4979) MCS /